NASDAQ$UFPT
UFP Technologies Inc · Q1 2020 earnings
Q1 2020 earnings · · Investor relations
Briefing
UFP Technologies reported modest gains in Q1 2020, with medical sales growth offsetting declines in non-medical markets amidst the COVID-19 pandemic.
UFP Technologies announced Q1 2020 results with a 2% increase in sales and a 4% increase in net income compared to Q1 2019. The company's medical sales grew significantly, offsetting declines in non-medical markets due to the COVID-19 pandemic.
- UFP Technologies reported net income of $3.9 million, or $0.52 per diluted share, for Q1 2020.
- Sales for Q1 2020 were $48.3 million, a 2% increase compared to Q1 2019 sales of $47.3 million.
- Medical sales grew by 16%, offsetting declines in non-medical markets.
- The company is taking steps to safeguard employees, including enhanced cleaning, temperature monitoring, and social distancing.
Headline financials
Revenue & EPS history
UFP Technologies · Revenue · Quarterly
$48.3M
Revenue by segment
UFP Technologies · $7.73M total across 1 segment · Q1 2020
- Medical$7.73M+15.8%100.0%
Forward guidance
UFP Technologies anticipates Q2 and likely Q3 will be adversely affected by the COVID-19 crisis but is focused on potential acquisitions and has increased raw materials and cash reserves to mitigate risk.
Tailwinds
- The company's supply chain, primarily U.S.-based, has been meeting its needs.
- UFP Technologies has increased its raw materials and cash reserves to mitigate risk.
- The company has sharpened its focus on potential acquisitions.
- UFP Technologies has a solid balance sheet.
- All UFP factories are deemed essential businesses and are up and running.
Headwinds
- Orders related to elective surgeries have slowed.
- Non-medical markets such as automotive and consumer have slowed dramatically.
- Attendance has slipped somewhat due to COVID-19.
- It is difficult to predict the net impact of the COVID-19 crisis.
- The company anticipates Q2 and likely Q3 will be adversely affected.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2020
+2.7%
Avg return
Earnings day
+3.1%
Avg return
5 days after
+5.5%
Avg return
30 days after
66%
43 / 65 earnings
Positive
+24.0%
Q1 2024
Best reaction
-11.6%
Q3 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +4.2% | -1.0% | +1.1% | |
| Q4 2025 | +0.3% | -15.1% | -21.2% | |
| Q3 2025 | +12.2% | +13.6% | +8.6% | |
| Q1 2025 | +11.2% | +19.8% | +23.6% | |
| Q4 2024 | +9.4% | -5.5% | -15.7% | |
| Q3 2024 | +23.8% | +24.2% | +4.5% | |
| Q2 2024 | +2.8% | -5.4% | +7.7% | |
| Q1 2024 | +24.0% | +24.5% | +26.4% | |
| Q4 2023 | +10.5% | +11.3% | +26.2% | |
| Q3 2023 | -11.6% | -8.0% | +6.9% | |
| Q2 2023 | -5.5% | -6.3% | -9.7% | |
| Q1 2023 | +5.8% | +2.0% | +13.9% | |
| Q4 2022 | +10.8% | +2.9% | +16.5% | |
| Q3 2022 | +16.4% | +21.5% | +31.6% | |
| Q2 2022 | +11.2% | +11.1% | +14.1% | |
| Q1 2022 | +5.9% | +3.1% | +14.2% | |
| Q4 2021 | -1.0% | -11.1% | +1.3% | |
| Q3 2021 | +4.1% | +6.8% | +7.6% | |
| Q2 2021 | +9.6% | +12.5% | +14.8% | |
| Q1 2021 | +8.1% | +8.8% | +15.4% | |
| Q4 2020 | +1.4% | -7.8% | -0.7% | |
| Q3 2020 | +13.2% | +18.9% | +25.0% | |
| Q2 2020 | +3.7% | +2.5% | -6.4% | |
| Q1 2020 | +1.3% | +7.1% | +10.0% | |
| Q4 2019 | +3.0% | -4.2% | -28.6% | |
| Q3 2019 | -0.2% | +1.3% | +7.7% | |
| Q2 2019 | +2.6% | -1.4% | -2.2% | |
| Q1 2019 | +2.8% | +3.6% | +5.0% | |
| Q4 2018 | -1.4% | -0.2% | +8.6% | |
| Q3 2018 | -0.8% | -1.8% | +5.1% | |
| Q2 2018 | +2.7% | +10.2% | +7.6% | |
| Q1 2018 | -0.6% | -3.2% | -6.2% | |
| Q4 2017 | -3.3% | -1.4% | +3.7% | |
| Q3 2017 | -10.1% | -11.1% | -9.0% | |
| Q2 2017 | -3.3% | -3.8% | -8.0% | |
| Q1 2017 | +1.7% | +1.1% | +4.9% | |
| Q4 2016 | +0.4% | +1.2% | +5.7% | |
| Q3 2016 | -4.6% | -3.5% | -4.6% | |
| Q2 2016 | +3.3% | +2.9% | +7.5% | |
| Q1 2016 | +1.3% | — | — | |
| Q4 2015 | +5.6% | — | — | |
| Q3 2015 | -0.6% | — | — | |
| Q2 2015 | +12.7% | — | — | |
| Q1 2015 | -2.7% | — | — | |
| Q4 2014 | -7.5% | — | — | |
| Q3 2014 | +0.9% | — | — | |
| Q2 2014 | -2.1% | — | — | |
| Q1 2014 | -1.2% | — | — | |
| Q4 2013 | +0.1% | — | — | |
| Q3 2013 | -0.9% | — | — | |
| Q2 2013 | +1.4% | — | — | |
| Q1 2013 | -3.4% | — | — | |
| Q4 2012 | -0.6% | — | — | |
| Q3 2012 | -2.5% | — | — | |
| Q2 2012 | +1.3% | — | — | |
| Q1 2011 | +2.5% | — | — | |
| Q1 2012 | +0.6% | — | — | |
| Q4 2009 | -3.0% | — | — | |
| Q4 2011 | -3.0% | — | — | |
| Q3 2010 | +2.6% | — | — | |
| Q3 2011 | +2.6% | — | — | |
| Q4 2010 | +1.3% | — | — | |
| Q2 2010 | +1.3% | — | — | |
| Q2 2011 | +1.3% | — | — | |
| Q1 2010 | +0.5% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro